0007

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766)

Market Closed
12 Dec, 06:57
XSHE XSHE
¥
28. 87
+0.16
+0.56%
¥
27.53B Market Cap
- P/E Ratio
1.87% Div Yield
10,872,814 Volume
- Eps
¥ 28.71
Previous Close
Day Range
28.51 29.07
Year Range
14.21 30.2
Want to track 000766 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

000766 closed today higher at ¥28.87, an increase of 0.56% from yesterday's close, completing a monthly decrease of -0.69% or ¥0.2. Over the past 12 months, 000766 stock gained 84.12%.
000766 is not paying dividends to its shareholders.
The last earnings report, released on Jun 20, 2024, exceeded the consensus estimates by 0.01%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

000766 Chart

Similar

Weichai Power Co., Ltd.
¥ 17.96
+2.63%
Chongqing Changan Automobile Co., Ltd.
¥ 11.64
+0.34%
Yunnan Baiyao Group Co., Ltd.
¥ 55.83
+0.05%
Tianqi Lithium Corporation
¥ 51.63
-2.77%
Guangzhou Tinci Materials Technology Co., Ltd.
¥ 38.22
-3.73%

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766) FAQ

What is the stock price today?

The current price is ¥28.87.

On which exchange is it traded?

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000766.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.87%.

What is its market cap?

As of today, the market cap is 27.53B.

Has Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Yufu Zhang CEO
XSHE Exchange
CNE000000735 ISIN
CN Country
1,532 Employees
- Last Dividend
25 May 2001 Last Split
18 Apr 1997 IPO Date

Overview

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. is a prominent entity specializing in the research, development, manufacture, and sale of pharmaceutical products in China. Since its establishment in 1990, the company has dedicated itself to offering a wide range of medications, including traditional Chinese medicine, Chinese and western raw materials, as well as biochemical preparations. With a focus on integrating ancient wisdom with modern technology, Tonghua Golden-Horse is positioned at the forefront of the pharmaceutical industry in China, contributing significantly to health and wellness through its extensive product portfolio. Based in Tonghua, China, the company stands as a stalwart in blending tradition with innovation to address various healthcare needs.

Products and Services

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. offers a comprehensive range of products and services, categorized into traditional Chinese medicines and Western medicines:

  • Anticancer: The company develops medications aimed at combating various types of cancers, leveraging both traditional Chinese medicine approaches and modern biochemical formulations to offer patients effective treatment options.
  • Gynecological Medications: A range of products focusing on women's health issues, including fertility and menstrual cycle regulation, highlighting the company's commitment to addressing the specific healthcare needs of women.
  • Rheumatic and Osteopathy Medications: Medications designed to treat rheumatic conditions and bone diseases, showcasing the use of traditional Chinese medicine in alleviating pain and improving mobility.
  • Urology: Treatments for urinary system conditions, reflecting the company's broader healthcare reach in addressing vital body systems through both traditional and Western medicinal approaches.
  • Heat-clearing and Detoxifying Medications: Products aimed at purifying the body and balancing internal heat, embodying the traditional Chinese medicinal principle of harmony between internal elements.
  • Cardiovascular: Medications dedicated to the treatment and management of heart and blood vessel conditions, blending modern pharmacology with traditional practices.
  • Digestive Medications: A variety of treatments for digestive system disorders, underscoring the company's holistic approach to health by ensuring the core body system's optimal function.
  • Strengthening and Tonic Medications: Products designed to boost the body's overall energy and vitality, in line with traditional Chinese medicine's preventative and holistic health philosophy.
  • Respiratory: Medications for the treatment of respiratory system conditions, integrating traditional Chinese medicine techniques to improve pulmonary health.
  • Diabetes: Products aimed at managing and treating diabetes, showcasing the company’s contribution to battling one of the modern era's prevalent chronic diseases.
  • Senses Medications: Treatments focused on health issues related to the body’s sensory organs, including the eyes and ears, further broadening the scope of the company’s healthcare solutions.
  • Pediatric Medication: A specialized segment focused on children's health and well-being, offering safe and effective treatments for the younger population.
  • Western Medicines: In addition to its traditional Chinese medicine offerings, the company also manufactures and distributes a variety of Western medicines, demonstrating its versatility and adaptability in the global pharmaceutical landscape.

Contact Information

Address: No. 999, Jinma Road, Tonghua City, China, 134003
Phone: 86 43 5324 6712